Salesforce学習教材には、GoShikenPDFバージョン、ソフトバージョン、APPバージョンのさまざまなバージョンがあります。 コンピューターで勉強するのが好きでも、紙の資料を読むのが好きでも、ALS-Con-201学習資料はSalesforceあなたのニーズを満たすことができます。 ほとんどの時間、紙の学習資料を読むことに慣れている場合は、心配を解消できます。 ALS-Con-201試験クイズでは、この分野の顧客のニーズを完全に考慮します。 ALS-Con-201学習教材のバージョンは、お客様がSalesforce Certified Agentforce Life Sciences Consultant学習できるようになっているため、自由時間が十分に活用され、知識を統合できることがよくあります。
| トピック | 出題範囲 |
|---|---|
| トピック 1 |
|
| トピック 2 |
|
| トピック 3 |
|
| トピック 4 |
|
>> Salesforce ALS-Con-201模擬問題 <<
準備の時間が限られているので、多くの受験者はあなたのペースを速めることができます。 ALS-Con-201練習資料は、ALS-Con-201試験の質問に対する知識理解の誤りを改善し、実際のALS-Con-201試験に必要なものすべてを含みます。 ALS-Con-201トレーニングガイドを選択したことを後悔することはありません。対照的に、それらは不明瞭なコンテンツを感じることなくあなたの可能性を刺激します。 ALS-Con-201試験準備を取得した後、試験期間中に大きなストレスにさらされることはありません。
質問 # 55
Choose 1 option.
Cumulus Pharma is launching a new "Immunology Monthly" newsletter for its "Immunexis" product. The Agentforce Life Sciences Consultant should configure the Consent Management module so that field sales reps can capture opt-ins for this specific newsletter.
Which record should the consultant create to link the "Immunology Monthly" Communication Subscription to the "Immunexis" product record?
正解：A
解説：
Data Use Purpose is the correct answer. In Salesforce Life Sciences Cloud Consent Management, a Communication Subscription represents a specific subscription, such as a newsletter, and the consent model must also connect that subscription to the business purpose and relevant Life Sciences product. Salesforce's Life Sciences Help documentation specifically describes creating a Data Use Purpose record to associate a Life Sciences Marketable Product with a Communication Subscription. That directly matches the scenario: "Immunology Monthly" is the Communication Subscription, and "Immunexis" is the product record that must be linked for consent capture.
Engagement Channel Type is not correct because it represents the channel through which the HCP can be contacted, such as email, SMS, or other communication methods. It defines the communication channel, not the relationship between a subscription and a marketable product. Communication Subscription Consent is also not correct because it represents an individual customer's or HCP's consent preference for a subscription. In other words, that record is created or updated when the HCP opts in or opts out; it is not the setup record used to link the newsletter subscription to the product. Salesforce's Life Sciences standard object documentation also describes Communication Subscription Consent as representing a customer's consent to a communication subscription, reinforcing that it stores the HCP's consent outcome rather than the product-subscription configuration.
=========
質問 # 56
Choose 1 option.
A field sales rep facilitated a "Lunch and Learn" session with three different Healthcare Providers (HCPs) at a healthcare clinic. The interaction is logged as a Group Visit in the Agentforce Life Sciences mobile app.
How does the system automatically structure the data records for this interaction?
正解：A
解説：
Option C is correct because Life Sciences Cloud separates the overall visit activity from provider-specific visit details. In the Life Sciences Cloud data model, the Visit object tracks information related to a field representative's visit to a healthcare provider and is used for Customer Engagement. Salesforce's ProviderVisit object represents the details of a field user's visit to a healthcare provider. The Customer Engagement data model also explains that information entered in a provider visit typically includes product details, product messages, presentations, marketing items, and samples.
For a group visit such as a "Lunch and Learn" with three HCPs, the overall event is represented by the parent Visit record. Each attendee requires their own provider-specific visit detail record because each HCP may have different product discussions, messages, samples, signatures, or follow-up activities. Therefore, the system creates one parent Visit and separate child Provider Visit records for each HCP attendee.
Option A is incorrect because a multi-select lookup field is not the correct Life Sciences Cloud visit data model pattern. Option B is also not correct because it implies individual parent-level Visit records for every attendee, which would duplicate the overall group interaction. The correct structure is one parent Visit for the group interaction and three child Provider Visit records, one for each Healthcare Provider attendee.
質問 # 57
Choose 1 option.
An Agentforce Life Sciences Consultant needs to configure sample management rules. They must specify which types of Healthcare Organizations (HCOs) are eligible to receive samples and enforce that users must enter a batch number for every sample dropped.
Which subsection of Visit Settings should the consultant use for these configurations?
正解：A
解説：
The correct answer is C because the requirement is about sampling eligibility and validation behavior during visits. Salesforce Life Sciences sample management features support compliant handling and distribution of samples, and visit-related sample behavior is configured through visit settings and sample management setup. Salesforce Help describes sample management as enabling pharmaceutical companies to efficiently handle and distribute drug samples to providers, while the broader Customer Engagement setup includes Life Sciences mobile and visit configuration areas where these rules are applied.
The scenario includes two validation-style requirements. First, the consultant must specify which types of HCOs are eligible to receive samples. Second, the system must require users to enter a batch number for every sample drop. Both requirements are about enforcing rules during the sampling process, not about presenting product details or general sample item display.
Option A, Product Detailing Settings, is incorrect because product detailing is used to configure how products are discussed or presented during an engagement. It does not control HCO sample eligibility or mandatory batch entry. Option B, Samples and Items Settings, sounds related to sample availability, but the requirement is specifically about compliance validation. Option C, Sample and Validation Settings, is the correct subsection because it governs sample-related validation behavior, including eligibility and required information such as batch number entry. Therefore, the consultant should use Sample and Validation Settings.
=========
質問 # 58
Choose 1 option.
Cumulus Pharma is implementing a feature where Healthcare Providers (HCPs) sign for drug samples on an iPad. The company's compliance team states that, to meet Food and Drug Administration (FDA) 21 CFR Part 11 requirements, a simple image of the signature is insufficient; the system must link the signature to the data and the user's credentials at the exact moment of signing.
Which feature generates this tamper-evident audit trail?
正解：A
解説：
Digital Verification is the correct answer because Salesforce Life Sciences resources describe it as the native capability used to manage electronic signatures in Salesforce and support an organization's 21 CFR Part 11 compliance requirements. Salesforce Help states that Electronic Signatures can be set up using the Digital Verifications feature, allowing signatures to be managed in Salesforce instead of relying on a third-party application. It also references creating a "signature trail," which is the key concept in this question: the signature is not just a stored image, but part of a controlled verification process tied to the signed record and signer context.
Field Audit Trail is not the best answer because it tracks field history and retention for data changes; it does not provide the electronic-signature process required for HCP sample acknowledgments. Adobe Sign is also not the best answer because the question asks for the Salesforce Life Sciences feature that generates the audit trail inside the Life Sciences process. The Salesforce Developer Guide also identifies Digital Verification standard objects as part of the electronic-signature data model, reinforcing that Digital Verification is the Life Sciences capability designed for this use case.
質問 # 59
Choose 1 option.
A field sales rep has logged personal time off for next Friday. However, they accidentally attempt to schedule a provider visit with a Healthcare Provider (HCP) during that same time slot. The system needs to prevent this action. The solution must use the standard Time Off Territory (TOT) configuration to enforce this restriction as a hard stop.
Which configuration should an Agentforce Life Sciences Consultant verify in the Visit/Calendar settings?
正解：C
解説：
Option B is correct because the requirement is specifically to prevent visit creation when a Visit overlaps with a Time Off Territory record. Salesforce Life Sciences documentation references Time Off Territory overlapping rules as the standard mechanism that prevents creating visits during TOT events. Salesforce's Winter '26 Customer Engagement package patch notes also mention an issue where a visit could be created during a Time Off Territory event, bypassing the overlapping rule that should have prevented creation. That confirms TOT overlapping rules are the expected standard control for this scenario.
Because the business wants a hard stop, the overlapping rule behavior must be set to "Error." This means the rep receives an error and cannot proceed with scheduling the visit while it conflicts with the TOT time block.
Option A is incorrect because a custom validation rule on Visit would duplicate a standard Life Sciences calendar/TOT capability and may not handle the full mobile scheduling experience correctly. Option C is also not the best answer because "Block Activity on Conflict" on the TOT record type is not the documented standard configuration in the Life Sciences Visit/Calendar settings. The correct standard configuration is to use TOT Overlapping Rules and set the overlap behavior to Error. This prevents scheduling visits during the rep's logged time off.
=========
質問 # 60
......
弊社が提供したALS-Con-201問題集がほかのインターネットに比べて問題のカーバ範囲がもっと広くて対応性が強い長所があります。GoShikenが持つべきなSalesforce問題集を提供するサイトでございます。
ALS-Con-201テスト対策書: https://www.goshiken.com/Salesforce/ALS-Con-201-mondaishu.html